Grant: Research Tools and Instruments - Category 1 (<$150,000)
York University
$148,390.00
Instrumentation for Discovery and Validation of Cancer Subtypes through Analysis of MicroRNA Signatures
EF 2012-13
Résumé
Proposed instrumentation for discovery of cancer subtypes through analysis of miRNA signatures is crucial for our research program concerned with the development of technologies for personalized cancer medicine. Within each cancer type there are multiple subtypes that exhibit different levels of malignancy and require different therapies. MiRNAs are very promising molecular markers for accurately identifying cancer subtypes as every cancer subtype is presumably associated with a unique quantitative miRNA signature. Despite successful efforts to identify candidate miRNA markers of cancer, miRNA signatures have not yet been used for the discovery of cancer subtypes. The lack of a miRNA analysis technology that is (i) quantitative, (ii) highly-sensitive, (iii) rugged, and (iv) capable of simultaneously analyzing multiple miRNAs is arguably the major challenge on our way to practical use of miRNA markers in personalized cancer medicine. Our research program focuses on the development of a suitable technology. The instrumental platform for this technology is our recent invention: capillary electrophoresis (CE) with confocal time-resolved fluorescence detection through an embedded capillary interface. The methodological platform is our other recent invention: a CE-based direct quantitative analysis of multiple miRNAs. Here we propose to assemble an instrument for analysis of miRNA signatures with a sensitivity equivalent to 1 copy of miRNA per cell. Four trainees (1 undergraduate student, 2 graduate students, and 1 PDF) are currently working on miRNA detection projects supported by two operating grants totaling 140,000 per year. Training of these researchers critically depends on the availability of the proposed instrument. If the laboratory does not get the instrument in 2013 then our research in this direction will be stalled. This, in turn, could result in the loss of our leading position in direct miRNA detection research. The delay in acquiring the proposed instrument would also dramatically affect the HQP training process.
Programme
Research Tools and Instruments - Category 1 (<$150,000)
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
439794-2013
Name nom
Krylov, Sergey
Department département
Chemistry
Organization id
38
Institution établissement
York University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2013
Award amount
148390
Program id
EQPEQ
Program name en
Research Tools and Instruments - Category 1 (<$150,000)
Program name fr
Outils et instruments de recherche - catégorie 1 (<150 000$)
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Bioanalytical chemistry
Research subject fr
Chimie bioanalytique
Partie
1
Nb partie
1
Application title
Instrumentation for Discovery and Validation of Cancer Subtypes through Analysis of MicroRNA Signatures
Keyword
NSERC
Application summary
Proposed instrumentation for discovery of cancer subtypes through analysis of miRNA signatures is crucial for our research program concerned with the development of technologies for personalized cancer medicine. Within each cancer type there are multiple subtypes that exhibit different levels of malignancy and require different therapies. MiRNAs are very promising molecular markers for accurately identifying cancer subtypes as every cancer subtype is presumably associated with a unique quantitative miRNA signature. Despite successful efforts to identify candidate miRNA markers of cancer, miRNA signatures have not yet been used for the discovery of cancer subtypes. The lack of a miRNA analysis technology that is (i) quantitative, (ii) highly-sensitive, (iii) rugged, and (iv) capable of simultaneously analyzing multiple miRNAs is arguably the major challenge on our way to practical use of miRNA markers in personalized cancer medicine. Our research program focuses on the development of a suitable technology. The instrumental platform for this technology is our recent invention: capillary electrophoresis (CE) with confocal time-resolved fluorescence detection through an embedded capillary interface. The methodological platform is our other recent invention: a CE-based direct quantitative analysis of multiple miRNAs. Here we propose to assemble an instrument for analysis of miRNA signatures with a sensitivity equivalent to 1 copy of miRNA per cell. Four trainees (1 undergraduate student, 2 graduate students, and 1 PDF) are currently working on miRNA detection projects supported by two operating grants totaling 140,000 per year. Training of these researchers critically depends on the availability of the proposed instrument. If the laboratory does not get the instrument in 2013 then our research in this direction will be stalled. This, in turn, could result in the loss of our leading position in direct miRNA detection research. The delay in acquiring the proposed instrument would also dramatically affect the HQP training process.